1
Home
Companies

Helius Medical Technologies

#9059

Rank

$115.64M

Marketcap

US United States

Country

Helius Medical Technologies
Leadership team

Mr. Dane Carl Andreeff (Pres, CEO & Director)

Mr. Jeffrey S. Mathiesen CPA, CPA (CFO, Treasurer, Sec. & Director)

Dr. Antonella Favit-Van Pelt M.D., Ph.D. (Chief Medical Officer)

Products/ Services
Biotechnology, Health Care, Health Diagnostics
Headquarters
Newtown, Pennsylvania, United States
Established
2014
Company Registration
SEC CIK number: 0001610853
Revenue
500K - 2M
Traded as
HSDT
Social Media
URL
https://heliusmedical.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.
History

Helius Medical Technologies was founded in 2003 as Neuronix Ltd. based in Tel Aviv, Israel, under the guidance of a team of accomplished and entrepreneurial scientists who wanted to develop technological solutions for neurological disorders. In 2014, the company rebranded to Helius Medical Technologies and began to transition from a research and development organization to a commercial organization with a focus on novel and non-invasive therapies for neurological disorders.

Mission
Helius is dedicated to providing innovative non-invasive therapies that enhance functional recovery for people with neurological disorder with a commitment to providing patient support in a compassionate and caring environment.
Vision
Helius' vision is to become the leader in non-invasive technology-enabled therapies and related healthcare services, with a focus on improving the lives of people with neurological disorders.
Key Team

Mr. Lawrence Picciano (Sr. VP of Engineering, Quality & Regulatory Affairs)

Dr. Brian W. Bapty Ph.D. (VP of Strategy and Bus. Devel.)

Recognition and Awards
Helius has recieved awards from the Global Neuroscience Innovation Forum, MedTech Breakthrough, Technology Fast 500. In 2020, Helius was named as a “Big Brain Award Winner” during the 5th Annual Global Neurotech & Imaging Conference.
References

https://in.investing.com/equities/helius-medical-technologies

https://finance.yahoo.com/quote/HSDT/profile?p=HSDT

https://www.crunchbase.com/organization/helius-medical-technologies

https://companiesmarketcap.com/

https://heliusmedical.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Helius Medical Technologies
Leadership team

Mr. Dane Carl Andreeff (Pres, CEO & Director)

Mr. Jeffrey S. Mathiesen CPA, CPA (CFO, Treasurer, Sec. & Director)

Dr. Antonella Favit-Van Pelt M.D., Ph.D. (Chief Medical Officer)

Products/ Services
Biotechnology, Health Care, Health Diagnostics
Headquarters
Newtown, Pennsylvania, United States
Established
2014
Company Registration
SEC CIK number: 0001610853
Revenue
500K - 2M
Traded as
HSDT
Social Media
URL
https://heliusmedical.com